Myriad Genetics
Myriad Genetics is a precision medicine company with deep expertise in companion diagnostics development and commercialization. Myriad partners with biopharmaceutical organizations across the full product lifecycle, offering biomarker discovery, assay development, clinical trial testing, regulatory strategy, and global CDx deployment. Leveraging validated platforms and extensive oncology experience, Myriad delivers robust, reproducible diagnostic solutions that align with targeted therapies. Our integrated laboratory infrastructure and regulatory capabilities enable streamlined approvals and scalable commercialization, supporting precision treatment strategies worldwide.